| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 49 | 2021 | 3770 | 4.270 |
Why?
|
| Receptors, IgG | 18 | 2021 | 565 | 4.210 |
Why?
|
| Macrophage-1 Antigen | 26 | 2018 | 286 | 3.780 |
Why?
|
| Glomerulonephritis | 12 | 2017 | 337 | 2.740 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 6 | 2022 | 346 | 1.520 |
Why?
|
| Antigen-Antibody Complex | 9 | 2021 | 513 | 1.500 |
Why?
|
| A Kinase Anchor Proteins | 3 | 2015 | 52 | 1.370 |
Why?
|
| Nephritis | 7 | 2018 | 149 | 1.190 |
Why?
|
| Immune Complex Diseases | 5 | 2016 | 52 | 1.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 6 | 2022 | 568 | 1.100 |
Why?
|
| Neutrophil Infiltration | 7 | 2013 | 394 | 1.100 |
Why?
|
| Endothelial Cells | 7 | 2022 | 3537 | 1.030 |
Why?
|
| P-Selectin | 17 | 2007 | 600 | 1.000 |
Why?
|
| Proto-Oncogene Proteins c-vav | 4 | 2011 | 91 | 0.990 |
Why?
|
| Endothelium, Vascular | 23 | 2022 | 4437 | 0.980 |
Why?
|
| Phagocytosis | 19 | 2016 | 1536 | 0.870 |
Why?
|
| Candidiasis | 3 | 2016 | 364 | 0.860 |
Why?
|
| Cell Adhesion | 21 | 2016 | 3096 | 0.850 |
Why?
|
| rap1 GTP-Binding Proteins | 3 | 2008 | 51 | 0.840 |
Why?
|
| Microtubules | 3 | 2015 | 1072 | 0.780 |
Why?
|
| Tumor Necrosis Factor-alpha | 14 | 2018 | 4357 | 0.770 |
Why?
|
| Monocytes | 6 | 2022 | 2574 | 0.750 |
Why?
|
| Receptors, CCR2 | 1 | 2022 | 215 | 0.740 |
Why?
|
| Glycosphingolipids | 1 | 2021 | 75 | 0.740 |
Why?
|
| Whooping Cough | 1 | 2021 | 85 | 0.740 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2022 | 277 | 0.730 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 1078 | 0.710 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2014 | 584 | 0.680 |
Why?
|
| Ligands | 5 | 2022 | 3277 | 0.650 |
Why?
|
| Measles | 1 | 2021 | 185 | 0.650 |
Why?
|
| Mice, Knockout | 42 | 2021 | 14396 | 0.640 |
Why?
|
| Kidney Glomerulus | 5 | 2017 | 568 | 0.630 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 5 | 2005 | 41 | 0.620 |
Why?
|
| Lupus Nephritis | 3 | 2019 | 318 | 0.610 |
Why?
|
| Lectins, C-Type | 4 | 2016 | 591 | 0.600 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 5 | 2013 | 256 | 0.590 |
Why?
|
| Cell Adhesion Molecules | 8 | 2016 | 1602 | 0.560 |
Why?
|
| Mice | 80 | 2022 | 81216 | 0.560 |
Why?
|
| Leukocytes | 13 | 2008 | 2030 | 0.550 |
Why?
|
| Immunoglobulin G | 9 | 2018 | 4546 | 0.550 |
Why?
|
| Inflammation | 15 | 2016 | 10757 | 0.540 |
Why?
|
| Integrins | 4 | 2012 | 840 | 0.540 |
Why?
|
| Animals | 95 | 2022 | 167940 | 0.540 |
Why?
|
| Blood-Testis Barrier | 1 | 2015 | 12 | 0.530 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 17 | 0.530 |
Why?
|
| Sertoli Cells | 1 | 2015 | 50 | 0.530 |
Why?
|
| Candida albicans | 4 | 2016 | 378 | 0.530 |
Why?
|
| Protein Kinase C-delta | 1 | 2016 | 114 | 0.510 |
Why?
|
| Cell Movement | 10 | 2021 | 5206 | 0.500 |
Why?
|
| von Willebrand Factor | 10 | 2003 | 673 | 0.500 |
Why?
|
| Reactive Oxygen Species | 11 | 2021 | 2138 | 0.480 |
Why?
|
| Reperfusion Injury | 4 | 2015 | 1023 | 0.460 |
Why?
|
| Endocytosis | 3 | 2021 | 960 | 0.460 |
Why?
|
| Aspergillosis | 1 | 2016 | 243 | 0.460 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 4 | 2012 | 21 | 0.450 |
Why?
|
| Antigens, Neoplasm | 2 | 2021 | 1999 | 0.440 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2016 | 825 | 0.440 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2013 | 68 | 0.440 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 2016 | 1128 | 0.430 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2016 | 2160 | 0.430 |
Why?
|
| Autoantibodies | 4 | 2019 | 2119 | 0.420 |
Why?
|
| Autoimmunity | 2 | 2019 | 1370 | 0.420 |
Why?
|
| Capillary Permeability | 4 | 2022 | 768 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 36 | 2021 | 22025 | 0.410 |
Why?
|
| Nitriles | 1 | 2017 | 955 | 0.410 |
Why?
|
| Testis | 1 | 2015 | 794 | 0.400 |
Why?
|
| Immunity, Innate | 4 | 2021 | 3046 | 0.400 |
Why?
|
| Aniline Compounds | 1 | 2017 | 1068 | 0.400 |
Why?
|
| Quinolines | 1 | 2017 | 759 | 0.400 |
Why?
|
| Arthus Reaction | 2 | 2008 | 14 | 0.400 |
Why?
|
| Germ Cells | 1 | 2015 | 635 | 0.390 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2016 | 377 | 0.390 |
Why?
|
| Immunologic Factors | 3 | 2018 | 1589 | 0.380 |
Why?
|
| Signal Transduction | 19 | 2021 | 23363 | 0.380 |
Why?
|
| Serum | 1 | 2012 | 211 | 0.380 |
Why?
|
| Interferon-beta | 1 | 2013 | 345 | 0.370 |
Why?
|
| T-Lymphocytes | 8 | 2021 | 10183 | 0.370 |
Why?
|
| Macrophages | 13 | 2022 | 5745 | 0.370 |
Why?
|
| Kidney | 7 | 2016 | 7072 | 0.370 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2011 | 87 | 0.370 |
Why?
|
| Shwartzman Phenomenon | 2 | 2008 | 9 | 0.360 |
Why?
|
| Cytokines | 10 | 2021 | 7345 | 0.360 |
Why?
|
| Blood Platelets | 8 | 2009 | 2522 | 0.350 |
Why?
|
| src-Family Kinases | 2 | 2017 | 534 | 0.350 |
Why?
|
| Lymph Nodes | 4 | 2021 | 3491 | 0.340 |
Why?
|
| Complement C3 | 3 | 2008 | 451 | 0.330 |
Why?
|
| Kidney Diseases | 4 | 2014 | 2093 | 0.330 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 1006 | 0.330 |
Why?
|
| Integrin alpha4beta1 | 2 | 2016 | 119 | 0.320 |
Why?
|
| Cells, Cultured | 20 | 2022 | 18968 | 0.320 |
Why?
|
| Arthritis, Experimental | 1 | 2011 | 292 | 0.310 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 724 | 0.310 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1483 | 0.310 |
Why?
|
| Receptors, Immunologic | 3 | 2011 | 1434 | 0.310 |
Why?
|
| Basement Membrane | 5 | 2018 | 348 | 0.300 |
Why?
|
| Kidney Failure, Chronic | 3 | 2016 | 2469 | 0.300 |
Why?
|
| Peritonitis | 6 | 2016 | 370 | 0.300 |
Why?
|
| Complement System Proteins | 5 | 2005 | 782 | 0.280 |
Why?
|
| Lymphocyte Activation | 3 | 2016 | 5498 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1655 | 0.280 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2006 | 93 | 0.270 |
Why?
|
| Meningitis | 2 | 1999 | 218 | 0.270 |
Why?
|
| Pancreatic Elastase | 1 | 2006 | 128 | 0.270 |
Why?
|
| E-Selectin | 6 | 2001 | 576 | 0.260 |
Why?
|
| Apoptosis | 8 | 2009 | 9497 | 0.260 |
Why?
|
| Endothelium | 8 | 2018 | 764 | 0.250 |
Why?
|
| Proteinuria | 5 | 2005 | 594 | 0.250 |
Why?
|
| Mice, Mutant Strains | 10 | 2009 | 1760 | 0.250 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 2250 | 0.240 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1344 | 0.240 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2021 | 305 | 0.240 |
Why?
|
| Umbilical Veins | 6 | 2004 | 426 | 0.240 |
Why?
|
| Complement C1q | 1 | 2004 | 94 | 0.230 |
Why?
|
| Carrier Proteins | 3 | 2015 | 4938 | 0.230 |
Why?
|
| Zebrafish | 1 | 2015 | 2996 | 0.230 |
Why?
|
| RNA Interference | 3 | 2016 | 2846 | 0.230 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7593 | 0.230 |
Why?
|
| Pemphigoid, Bullous | 1 | 2005 | 114 | 0.230 |
Why?
|
| Thrombosis | 2 | 2009 | 3052 | 0.220 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2012 | 663 | 0.220 |
Why?
|
| Antigens, CD | 6 | 2008 | 4002 | 0.220 |
Why?
|
| Dendritic Cells | 5 | 2021 | 2730 | 0.220 |
Why?
|
| Enzyme Activation | 4 | 2015 | 3604 | 0.210 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2021 | 581 | 0.210 |
Why?
|
| Respiratory Burst | 5 | 2006 | 110 | 0.210 |
Why?
|
| Venules | 4 | 2016 | 164 | 0.200 |
Why?
|
| Cell Communication | 2 | 2008 | 1642 | 0.200 |
Why?
|
| Rubella Vaccine | 1 | 2021 | 23 | 0.200 |
Why?
|
| Adherens Junctions | 1 | 2022 | 89 | 0.200 |
Why?
|
| Mumps Vaccine | 1 | 2021 | 16 | 0.200 |
Why?
|
| Phosphoproteins | 3 | 2008 | 2441 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 2296 | 0.190 |
Why?
|
| Humans | 66 | 2022 | 760261 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2021 | 2536 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2005 | 801 | 0.190 |
Why?
|
| Platelet Activation | 3 | 2018 | 661 | 0.180 |
Why?
|
| Mast Cells | 4 | 2005 | 1428 | 0.180 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2003 | 886 | 0.170 |
Why?
|
| Crosses, Genetic | 3 | 2019 | 751 | 0.170 |
Why?
|
| Transfection | 5 | 2012 | 5782 | 0.170 |
Why?
|
| Mice, Transgenic | 10 | 2018 | 9531 | 0.170 |
Why?
|
| Caspase 8 | 2 | 2014 | 188 | 0.170 |
Why?
|
| Neutrophil Activation | 2 | 2013 | 181 | 0.170 |
Why?
|
| Models, Immunological | 4 | 2005 | 513 | 0.160 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 1995 | 285 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2022 | 475 | 0.160 |
Why?
|
| Glomerular Basement Membrane | 2 | 2015 | 36 | 0.160 |
Why?
|
| Fish Oils | 1 | 2002 | 482 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2000 | 345 | 0.160 |
Why?
|
| Crush Syndrome | 1 | 2018 | 8 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2021 | 4355 | 0.150 |
Why?
|
| Antigen Presentation | 2 | 2021 | 1254 | 0.150 |
Why?
|
| Cytoplasmic Granules | 3 | 1998 | 575 | 0.150 |
Why?
|
| HL-60 Cells | 2 | 2017 | 363 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 854 | 0.150 |
Why?
|
| Acute Kidney Injury | 3 | 2018 | 1935 | 0.150 |
Why?
|
| Glycosylation | 2 | 2018 | 1097 | 0.150 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2018 | 357 | 0.140 |
Why?
|
| Protein Precursors | 2 | 1992 | 1135 | 0.140 |
Why?
|
| Antibodies | 4 | 2009 | 2424 | 0.140 |
Why?
|
| Actins | 3 | 2015 | 2049 | 0.140 |
Why?
|
| Disease Models, Animal | 13 | 2018 | 18134 | 0.140 |
Why?
|
| Jurkat Cells | 1 | 2018 | 736 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 2415 | 0.140 |
Why?
|
| Lactoferrin | 2 | 2016 | 100 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2017 | 140 | 0.140 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2008 | 162 | 0.140 |
Why?
|
| Rhabdomyolysis | 1 | 2018 | 155 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2018 | 4264 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 6 | 1992 | 1977 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 5784 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 540 | 0.130 |
Why?
|
| Cell Migration Assays, Leukocyte | 1 | 2015 | 8 | 0.130 |
Why?
|
| GPI-Linked Proteins | 2 | 2012 | 468 | 0.130 |
Why?
|
| K562 Cells | 2 | 2012 | 640 | 0.130 |
Why?
|
| Interleukin-17 | 2 | 2012 | 908 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2874 | 0.130 |
Why?
|
| Diabetic Nephropathies | 2 | 2014 | 988 | 0.130 |
Why?
|
| Leukocyte Elastase | 3 | 2016 | 114 | 0.130 |
Why?
|
| Cadherins | 2 | 2012 | 898 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.130 |
Why?
|
| Protein Structure, Secondary | 1 | 2018 | 1230 | 0.130 |
Why?
|
| Genes | 1 | 2019 | 1845 | 0.130 |
Why?
|
| Glucans | 3 | 2000 | 68 | 0.130 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2015 | 103 | 0.120 |
Why?
|
| Omentum | 1 | 2016 | 169 | 0.120 |
Why?
|
| Opsonin Proteins | 5 | 2003 | 147 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1998 | 557 | 0.120 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2016 | 159 | 0.120 |
Why?
|
| Aspergillus fumigatus | 1 | 2016 | 156 | 0.120 |
Why?
|
| Spermatogenesis | 1 | 2015 | 257 | 0.120 |
Why?
|
| Organelles | 2 | 2000 | 267 | 0.120 |
Why?
|
| Inclusion Bodies | 1 | 1996 | 281 | 0.120 |
Why?
|
| Rabbits | 3 | 2012 | 4773 | 0.120 |
Why?
|
| Thrombin | 2 | 2004 | 593 | 0.120 |
Why?
|
| Capillaries | 1 | 2017 | 745 | 0.120 |
Why?
|
| Selectins | 3 | 1999 | 101 | 0.110 |
Why?
|
| beta-Glucans | 1 | 2014 | 121 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3524 | 0.110 |
Why?
|
| Lipoxins | 1 | 1996 | 418 | 0.110 |
Why?
|
| Solubility | 3 | 2012 | 1088 | 0.110 |
Why?
|
| Ischemic Attack, Transient | 1 | 1999 | 899 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 1996 | 959 | 0.110 |
Why?
|
| Endosomes | 1 | 2015 | 519 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2016 | 825 | 0.110 |
Why?
|
| Intradermal Tests | 1 | 2012 | 42 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2002 | 1387 | 0.110 |
Why?
|
| Thrombospondins | 1 | 2013 | 193 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2015 | 593 | 0.110 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2013 | 112 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 803 | 0.100 |
Why?
|
| Complement C3c | 1 | 2012 | 7 | 0.100 |
Why?
|
| Models, Biological | 4 | 2014 | 9468 | 0.100 |
Why?
|
| Ureteral Obstruction | 1 | 2014 | 292 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2013 | 169 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 22066 | 0.100 |
Why?
|
| Thrombasthenia | 1 | 2012 | 22 | 0.100 |
Why?
|
| Antigen-Presenting Cells | 1 | 2015 | 967 | 0.100 |
Why?
|
| Receptors, CXCR3 | 1 | 2013 | 238 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2001 | 1351 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2016 | 547 | 0.100 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 333 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2008 | 3784 | 0.100 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 11902 | 0.100 |
Why?
|
| Macrophages, Peritoneal | 3 | 2002 | 237 | 0.100 |
Why?
|
| Membrane Glycoproteins | 4 | 2007 | 3731 | 0.100 |
Why?
|
| Receptors, Cell Surface | 3 | 2015 | 2825 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2021 | 2918 | 0.090 |
Why?
|
| Protein Transport | 4 | 2016 | 1966 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.090 |
Why?
|
| Th1 Cells | 1 | 2016 | 1033 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 4554 | 0.090 |
Why?
|
| Flow Cytometry | 4 | 2010 | 5873 | 0.090 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 116 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2012 | 565 | 0.090 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 999 | 0.090 |
Why?
|
| Cell Line | 7 | 2016 | 15626 | 0.090 |
Why?
|
| Complement C3b | 3 | 1999 | 99 | 0.090 |
Why?
|
| Blood Cell Count | 2 | 2004 | 398 | 0.090 |
Why?
|
| Lung | 4 | 2022 | 9989 | 0.090 |
Why?
|
| Protein Phosphatase 2 | 1 | 2012 | 236 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2716 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 1956 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2016 | 2486 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 1996 | 1017 | 0.080 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 4215 | 0.080 |
Why?
|
| Intercellular Junctions | 2 | 2013 | 197 | 0.080 |
Why?
|
| Synovitis | 1 | 2011 | 216 | 0.080 |
Why?
|
| Male | 22 | 2019 | 359413 | 0.080 |
Why?
|
| Mesangial Cells | 1 | 2009 | 23 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1120 | 0.080 |
Why?
|
| Macromolecular Substances | 6 | 1992 | 1433 | 0.080 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2009 | 144 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2009 | 348 | 0.080 |
Why?
|
| Splenomegaly | 2 | 2008 | 189 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2010 | 11064 | 0.080 |
Why?
|
| Lipopolysaccharides | 5 | 2007 | 2214 | 0.080 |
Why?
|
| Homeostasis | 3 | 2013 | 3305 | 0.080 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2009 | 98 | 0.080 |
Why?
|
| Leukocyte Rolling | 1 | 2008 | 71 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 877 | 0.080 |
Why?
|
| Weibel-Palade Bodies | 1 | 2007 | 19 | 0.080 |
Why?
|
| Skin | 6 | 2008 | 4468 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4573 | 0.080 |
Why?
|
| Tyrosine | 1 | 2012 | 1440 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10434 | 0.070 |
Why?
|
| Cysteine | 1 | 1992 | 897 | 0.070 |
Why?
|
| Amyloid | 1 | 2012 | 843 | 0.070 |
Why?
|
| Fibrin | 1 | 2009 | 505 | 0.070 |
Why?
|
| Type C Phospholipases | 1 | 2007 | 287 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2006 | 221 | 0.070 |
Why?
|
| Cell Separation | 2 | 2010 | 1720 | 0.070 |
Why?
|
| Receptors, Fc | 2 | 2001 | 534 | 0.070 |
Why?
|
| Microscopy, Electron | 3 | 2015 | 2558 | 0.070 |
Why?
|
| Species Specificity | 1 | 2011 | 2413 | 0.070 |
Why?
|
| Gene Expression | 4 | 2012 | 7592 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2010 | 5039 | 0.070 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 1726 | 0.070 |
Why?
|
| Hemidesmosomes | 1 | 2005 | 5 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2005 | 2473 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1697 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4637 | 0.060 |
Why?
|
| Superoxides | 1 | 2006 | 387 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 4286 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 3804 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2008 | 1955 | 0.060 |
Why?
|
| Thrombospondin 1 | 2 | 2004 | 257 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 563 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1972 | 0.060 |
Why?
|
| Mice, Inbred Strains | 5 | 2001 | 1765 | 0.060 |
Why?
|
| Graft Survival | 1 | 2015 | 3793 | 0.060 |
Why?
|
| Microcirculation | 3 | 2004 | 1279 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1811 | 0.060 |
Why?
|
| Tubulin | 1 | 2008 | 692 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2012 | 8314 | 0.060 |
Why?
|
| Edema | 1 | 2008 | 772 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2007 | 863 | 0.060 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 392 | 0.060 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2016 | 694 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1455 | 0.060 |
Why?
|
| Bone Marrow Cells | 3 | 2008 | 2424 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9629 | 0.060 |
Why?
|
| Brain | 5 | 2012 | 26912 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2012 | 4127 | 0.050 |
Why?
|
| Kupffer Cells | 2 | 2003 | 143 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 623 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2651 | 0.050 |
Why?
|
| Female | 25 | 2019 | 391011 | 0.050 |
Why?
|
| Microglia | 1 | 2012 | 1348 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2003 | 186 | 0.050 |
Why?
|
| Fluoroimmunoassay | 1 | 2002 | 30 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 2696 | 0.050 |
Why?
|
| Erythrocytes | 2 | 2004 | 2415 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1201 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2002 | 12100 | 0.050 |
Why?
|
| Acute Disease | 3 | 1998 | 7268 | 0.050 |
Why?
|
| Malaria, Cerebral | 1 | 2004 | 136 | 0.050 |
Why?
|
| Paclitaxel | 2 | 2001 | 1738 | 0.050 |
Why?
|
| Cattle | 2 | 2002 | 3847 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1699 | 0.050 |
Why?
|
| Diet | 2 | 2019 | 8008 | 0.050 |
Why?
|
| Fluorescence | 1 | 2004 | 750 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 3076 | 0.050 |
Why?
|
| Immunity, Cellular | 3 | 2009 | 1558 | 0.050 |
Why?
|
| Wound Healing | 2 | 2007 | 2786 | 0.050 |
Why?
|
| Sepsis | 1 | 2016 | 2594 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1843 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 6543 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2009 | 1174 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2014 | 4423 | 0.050 |
Why?
|
| Cold Temperature | 2 | 2003 | 780 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 1246 | 0.050 |
Why?
|
| Restriction Mapping | 2 | 1992 | 852 | 0.050 |
Why?
|
| Microvilli | 1 | 2001 | 233 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 730 | 0.050 |
Why?
|
| Thioglycolates | 2 | 1998 | 38 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2002 | 337 | 0.050 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2000 | 176 | 0.040 |
Why?
|
| Animals, Outbred Strains | 1 | 2019 | 20 | 0.040 |
Why?
|
| Caspases | 1 | 2003 | 878 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1992 | 2186 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 912 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2002 | 553 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 2019 | 182 | 0.040 |
Why?
|
| Interleukin-1 | 2 | 2001 | 1250 | 0.040 |
Why?
|
| Hepatitis, Animal | 1 | 1998 | 19 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 3217 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2000 | 404 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 890 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2012 | 1791 | 0.040 |
Why?
|
| Peritoneal Cavity | 1 | 1998 | 142 | 0.040 |
Why?
|
| Aorta | 2 | 2004 | 2042 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 6131 | 0.040 |
Why?
|
| Isoantibodies | 2 | 2004 | 661 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2012 | 9283 | 0.040 |
Why?
|
| Immune Sera | 3 | 2007 | 613 | 0.040 |
Why?
|
| RNA, Messenger | 5 | 2007 | 12762 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 1999 | 280 | 0.040 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2002 | 613 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17766 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2019 | 344 | 0.040 |
Why?
|
| Immunoglobulin M | 2 | 2000 | 1529 | 0.040 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1997 | 52 | 0.040 |
Why?
|
| Myoglobin | 1 | 2018 | 159 | 0.040 |
Why?
|
| Escherichia coli | 2 | 2016 | 4223 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 4312 | 0.040 |
Why?
|
| Periodontal Diseases | 1 | 2001 | 452 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 685 | 0.040 |
Why?
|
| Secretory Vesicles | 1 | 2018 | 128 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 2866 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3451 | 0.040 |
Why?
|
| Lectins | 1 | 1999 | 485 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1998 | 250 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1999 | 501 | 0.030 |
Why?
|
| Biodiversity | 1 | 2019 | 345 | 0.030 |
Why?
|
| Fungi | 1 | 2019 | 338 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 1997 | 281 | 0.030 |
Why?
|
| Histones | 2 | 2018 | 2583 | 0.030 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2018 | 287 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2018 | 900 | 0.030 |
Why?
|
| Lipoxygenase | 1 | 1996 | 72 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 4923 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 2222 | 0.030 |
Why?
|
| Cell Survival | 2 | 2003 | 5796 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 35 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1737 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2008 | 3604 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 1056 | 0.030 |
Why?
|
| DNA | 3 | 2018 | 7236 | 0.030 |
Why?
|
| Heme | 1 | 2018 | 313 | 0.030 |
Why?
|
| Kinetics | 4 | 2004 | 6378 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1996 | 173 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1999 | 598 | 0.030 |
Why?
|
| Peptides | 1 | 2007 | 4358 | 0.030 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1996 | 224 | 0.030 |
Why?
|
| Zymosan | 3 | 2000 | 136 | 0.030 |
Why?
|
| Disulfides | 2 | 1989 | 466 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2001 | 1036 | 0.030 |
Why?
|
| Point Mutation | 1 | 2000 | 1594 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 6 | 2016 | 9196 | 0.030 |
Why?
|
| Protein Binding | 3 | 2013 | 9336 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2016 | 293 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2013 | 11480 | 0.030 |
Why?
|
| Dermatitis, Contact | 1 | 1995 | 133 | 0.030 |
Why?
|
| Cell Count | 1 | 1998 | 1838 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 1135 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2018 | 3207 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 1997 | 491 | 0.030 |
Why?
|
| Eicosanoids | 1 | 1996 | 278 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 1828 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 1999 | 982 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1996 | 616 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 4739 | 0.030 |
Why?
|
| Granulation Tissue | 2 | 2007 | 92 | 0.030 |
Why?
|
| Spleen | 1 | 2019 | 2298 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 1996 | 544 | 0.030 |
Why?
|
| Liver | 3 | 2003 | 7512 | 0.030 |
Why?
|
| Cell Membrane | 3 | 2016 | 3683 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3448 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2012 | 81 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1997 | 1064 | 0.030 |
Why?
|
| Chemokines | 1 | 2016 | 962 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15273 | 0.030 |
Why?
|
| Immunization | 1 | 2016 | 1228 | 0.030 |
Why?
|
| Chimera | 1 | 1993 | 453 | 0.030 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2012 | 52 | 0.030 |
Why?
|
| Bacteria | 2 | 2019 | 2196 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2016 | 524 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1999 | 1500 | 0.020 |
Why?
|
| Microinjections | 1 | 2012 | 321 | 0.020 |
Why?
|
| RNA | 2 | 2009 | 2721 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 2101 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1056 | 0.020 |
Why?
|
| Cell Compartmentation | 2 | 1989 | 385 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 4 | 2001 | 6226 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 871 | 0.020 |
Why?
|
| Amino Acids | 1 | 2016 | 1715 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7854 | 0.020 |
Why?
|
| Ethylmaleimide | 1 | 1989 | 70 | 0.020 |
Why?
|
| Germinal Center | 1 | 2012 | 379 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2016 | 1511 | 0.020 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2001 | 303 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6242 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1670 | 0.020 |
Why?
|
| Chemokine CXCL9 | 1 | 2009 | 135 | 0.020 |
Why?
|
| Catenins | 1 | 2008 | 41 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2012 | 943 | 0.020 |
Why?
|
| Protein Engineering | 1 | 1992 | 541 | 0.020 |
Why?
|
| CHO Cells | 2 | 2002 | 1389 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2002 | 590 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2002 | 580 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 2895 | 0.020 |
Why?
|
| Lentivirus Infections | 1 | 2007 | 11 | 0.020 |
Why?
|
| Immunochemistry | 1 | 2007 | 119 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 3023 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12281 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 1667 | 0.020 |
Why?
|
| Interleukin-12 | 2 | 2001 | 584 | 0.020 |
Why?
|
| Half-Life | 1 | 2008 | 652 | 0.020 |
Why?
|
| Exocytosis | 2 | 2001 | 322 | 0.020 |
Why?
|
| Cricetinae | 2 | 2002 | 2427 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1989 | 2509 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 17628 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1989 | 1544 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 12532 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2008 | 230 | 0.020 |
Why?
|
| Interferon-gamma | 2 | 2009 | 3160 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1893 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2007 | 241 | 0.020 |
Why?
|
| Shear Strength | 1 | 2007 | 161 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 919 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 1996 | 2063 | 0.020 |
Why?
|
| Alleles | 2 | 1996 | 6900 | 0.020 |
Why?
|
| Monensin | 1 | 1985 | 30 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1663 | 0.020 |
Why?
|
| Plasmids | 1 | 1991 | 2277 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 13456 | 0.020 |
Why?
|
| Nephrotic Syndrome | 1 | 2009 | 391 | 0.020 |
Why?
|
| Tryptases | 1 | 2005 | 177 | 0.010 |
Why?
|
| Necrosis | 1 | 2009 | 1612 | 0.010 |
Why?
|
| Time Factors | 3 | 2012 | 40133 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2009 | 1400 | 0.010 |
Why?
|
| Furans | 1 | 1985 | 199 | 0.010 |
Why?
|
| Stem Cells | 2 | 1996 | 3525 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 6067 | 0.010 |
Why?
|
| Receptor, PAR-1 | 1 | 2004 | 114 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 2004 | 128 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 2178 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6775 | 0.010 |
Why?
|
| Plasmodium berghei | 1 | 2004 | 159 | 0.010 |
Why?
|
| Blood Coagulation Factors | 1 | 1985 | 366 | 0.010 |
Why?
|
| Rats | 2 | 1996 | 23695 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2056 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3443 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 201 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 1933 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2005 | 613 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 2001 | 44 | 0.010 |
Why?
|
| Receptors, Vitronectin | 1 | 2001 | 48 | 0.010 |
Why?
|
| Integrin alphaV | 1 | 2001 | 55 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2002 | 235 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 1375 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 2000 | 34 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2918 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 1021 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 39254 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 721 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 318 | 0.010 |
Why?
|
| Receptors, Complement 3b | 1 | 2000 | 135 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10829 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 3735 | 0.010 |
Why?
|
| Glucuronidase | 1 | 2001 | 203 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2001 | 316 | 0.010 |
Why?
|
| Membrane Fusion | 1 | 2001 | 266 | 0.010 |
Why?
|
| Leukemia P388 | 1 | 1999 | 14 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2001 | 260 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2012 | 5120 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2001 | 435 | 0.010 |
Why?
|
| Phenotype | 2 | 2013 | 16543 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2001 | 421 | 0.010 |
Why?
|
| Photoaffinity Labels | 1 | 1999 | 85 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 444 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2012 | 41317 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2001 | 364 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1999 | 322 | 0.010 |
Why?
|
| Genotype | 1 | 1993 | 12959 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2001 | 321 | 0.010 |
Why?
|
| Gingiva | 1 | 2001 | 406 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 317 | 0.010 |
Why?
|
| Blood | 1 | 2001 | 586 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 3839 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2001 | 600 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12156 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 915 | 0.010 |
Why?
|
| Alveolar Bone Loss | 1 | 2001 | 390 | 0.010 |
Why?
|
| Risk Factors | 3 | 2012 | 74269 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 688 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12806 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 2001 | 978 | 0.010 |
Why?
|
| Virulence | 1 | 2001 | 1295 | 0.010 |
Why?
|
| Diet, Atherogenic | 1 | 1997 | 93 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2002 | 732 | 0.010 |
Why?
|
| Mesenteric Veins | 1 | 1997 | 83 | 0.010 |
Why?
|
| Heparin | 1 | 2004 | 1655 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 1997 | 224 | 0.010 |
Why?
|
| Skin Window Technique | 1 | 1995 | 22 | 0.010 |
Why?
|
| Periodontitis | 1 | 2001 | 560 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 1032 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 1690 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 642 | 0.010 |
Why?
|
| Back | 1 | 1995 | 64 | 0.010 |
Why?
|
| Oxazolone | 1 | 1995 | 61 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2852 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2001 | 1041 | 0.010 |
Why?
|
| Obesity | 1 | 1997 | 12915 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13505 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1996 | 251 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2001 | 2363 | 0.010 |
Why?
|
| Ulcer | 1 | 1996 | 205 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 1234 | 0.010 |
Why?
|
| Middle Aged | 3 | 2015 | 220175 | 0.010 |
Why?
|
| Adult | 3 | 2015 | 219847 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1999 | 2627 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1998 | 1518 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15827 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 21378 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1997 | 792 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2012 | 80301 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 924 | 0.010 |
Why?
|
| Organ Preservation | 1 | 1996 | 379 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1997 | 882 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4494 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9388 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1998 | 3800 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1600 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 6050 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2001 | 2978 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 2204 | 0.010 |
Why?
|
| Carcinoma | 1 | 2001 | 2334 | 0.010 |
Why?
|
| Dietary Fats | 1 | 1997 | 1992 | 0.010 |
Why?
|
| Triglycerides | 1 | 1997 | 2476 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4168 | 0.000 |
Why?
|
| Cholesterol | 1 | 1997 | 2925 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1996 | 1402 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8945 | 0.000 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1986 | 21 | 0.000 |
Why?
|
| Ammonium Chloride | 1 | 1986 | 72 | 0.000 |
Why?
|
| Acetylglucosaminidase | 1 | 1986 | 67 | 0.000 |
Why?
|
| Tunicamycin | 1 | 1986 | 108 | 0.000 |
Why?
|
| Swainsonine | 1 | 1985 | 9 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 9590 | 0.000 |
Why?
|
| Base Sequence | 1 | 1996 | 12447 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 29950 | 0.000 |
Why?
|
| Alkaloids | 1 | 1985 | 194 | 0.000 |
Why?
|
| Sex Factors | 1 | 1997 | 10530 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 20048 | 0.000 |
Why?
|
| Heart Transplantation | 1 | 1996 | 3217 | 0.000 |
Why?
|
| Aged | 1 | 2012 | 168995 | 0.000 |
Why?
|
| Aging | 1 | 1997 | 8641 | 0.000 |
Why?
|
| Glycoproteins | 1 | 1985 | 2208 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2001 | 54263 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 21065 | 0.000 |
Why?
|
| Pregnancy | 1 | 1986 | 29725 | 0.000 |
Why?
|